INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | 155 | $2,864 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 12,021 | $222,869 | 0.00% |
| Citadel Advisors | 83,800 | $1,553,652 | 0.00% |
| Citadel Advisors | 81,972 | $1,519,761 | 0.00% |
| GTS SECURITIES LLC | 11,700 | $216,918 | 0.00% |
| GTS SECURITIES LLC | 13,300 | $246,582 | 0.00% |
| Daiwa Securities Group Inc. | 167 | $3 | 0.00% |
| SIMPLEX TRADING, LLC | 1,384 | $25 | 0.00% |
| Geneos Wealth Management Inc. | 400 | $7,416 | 0.00% |
| Lindbrook Capital, LLC | 162 | $3,003 | 0.00% |
External links
This page lists INTERCEPT PHARMACEUTICALS IN's shareholders in Q3 2023. To view INTERCEPT PHARMACEUTICALS IN's shareholder history, click here.